Drug Type Small molecule drug |
Synonyms Trichlormethiazide/Irbesartan, S-474474, IRTRA + [1] |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (28 Jun 2013), |
Regulation- |
Molecular FormulaC8H8Cl3N3O4S2 |
InChIKeyLMJSLTNSBFUCMU-UHFFFAOYSA-N |
CAS Registry133-67-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | JP | 28 Jun 2013 |